-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UHmQHvSlt0AYn2PP1gTyzk/V/plHDGd6m1nh7Pi16GhBxx+F72G/ba7lKs0xhM15 BUvbkOZMq3OnB+QXO9BjKA== 0001298528-10-000001.txt : 20100413 0001298528-10-000001.hdr.sgml : 20100413 20100412175332 ACCESSION NUMBER: 0001298528-10-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100413 DATE AS OF CHANGE: 20100412 EFFECTIVENESS DATE: 20100413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Artielle ImmunoTherapeutics Inc CENTRAL INDEX KEY: 0001298528 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-140451 FILM NUMBER: 10745756 BUSINESS ADDRESS: STREET 1: 9020 SW WASHINGTON SQUARE RD STREET 2: SUITE 450 CITY: TIGARD STATE: OR ZIP: 97223 BUSINESS PHONE: 503-626-1144 MAIL ADDRESS: STREET 1: 9020 SW WASHINGTON SQUARE RD STREET 2: SUITE 450 CITY: TIGARD STATE: OR ZIP: 97223 FORMER COMPANY: FORMER CONFORMED NAME: Artielle Immuno Therapeutics Inc DATE OF NAME CHANGE: 20040726 D 1 primary_doc.xml X0704 D LIVE 0001298528 Artielle ImmunoTherapeutics Inc 9020 SW Washington Square Road Suite 450 Tigard OR OREGON 97223 503 626-1144 DELAWARE Artielle Immuno Therapeutics Inc Corporation true Adolph J. Ferro 9020 SW Washington Square Road Suite 450 Tigard OR OREGON 97223 Executive Officer Director Gilbert N. Miller 9020 SW Washington Square Road Suite 450 Tigard OR OREGON 97223 Executive Officer Shahab Fatheazam 9020 SW Washington Square Road Suite 450 Tigard OR OREGON 97223 Director Peter McWilliams c/o Sanderling Ventures 400 South El Camino Real, Suite 1200 San Mateo CA CALIFORNIA 94402-1708 Director Paul Quadros c/o Tenex Greenhouse Ventures LLC 533 Airport Blvd., Ste 400 Burlingame CA CALIFORNIA 94010 Director Allan Wolfe c/o Utah Ventures, 2755 E. Cottonwood Parkway, Suite 520 Salt Lake City UT UTAH 84121 Director J. Brock Metcalf c/o Reference Capital Management LLC 12909 SW 68th Parkway, Suite 430 Portland OR OREGON 97223 Director Biotechnology Decline to Disclose 06 false 2010-02-19 false true true true 1) Convertible Promissory Notes, the underlying shares of Preferred Stock and Common Stock isued on conversion thereof: 2) Common Stock Warrants and the underlying shares of Common Stock issuable upon exercise. false 0 700000 185740 514260 false 5 0 0 0 false Artielle ImmunoTherapeutics Inc /s/ Gilbert N. Miller Gilbert N. Miller Executive Vice President 2010-04-12 -----END PRIVACY-ENHANCED MESSAGE-----